Update on clinical options for the management of allergic rhinitis

Mohsen Nasir, J. Andrew Grant

Research output: Contribution to journalReview articlepeer-review


Allergic rhinitis is a common, chronic medical condition affecting millions of people worldwide. Uncontrolled disease has been associated with impairments in quality of life and decreased economic productivity. Proper identification and control of relevant co- morbid conditions is essential for optimal rhinitis control. Management of allergic rhinitis includes identification of relevant allergens, education on avoidance measures, medications and immunotherapy. First-line therapy includes the use on an intranasal steroid. Other treatment options include oral or intranasal antihistamines, decongestants, leukotriene receptor antagonists, mast cell stabilizers or anticholinergic agents. Immunotherapy is an effective treatment option for refractory disease.

Original languageEnglish (US)
Pages (from-to)379-394
Number of pages16
JournalClinical Medicine Insights: Therapeutics
StatePublished - 2011
Externally publishedYes


  • Allergic rhinitis
  • Antihistamines
  • Avoidance measures
  • Immunotherapy
  • Intranasal steroids

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science


Dive into the research topics of 'Update on clinical options for the management of allergic rhinitis'. Together they form a unique fingerprint.

Cite this